Improving colorectal cancer surveillance for survivors
Official title: A Pragmatic Randomized Controlled Trial to Evaluate the Effectiveness of an Intervention to Promote Guideline-Concordant Colorectal Cancer Surveillance
Funded at University of Michigan at Ann Arbor · NIH-10939665 · Data updated 2026-11-12
This study is looking at a program called Current Together After Cancer (CTAC) to see how it can help colorectal cancer survivors and their supporters feel more confident and informed about keeping up with important follow-up care like blood tests and scans.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project start | August 1, 2024 |
| Project end | July 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $591,691 |
| NIH project number | 1R01CA293394-01 |
| Project ID | NIH-10939665 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who have survived colorectal cancer and are navigating the transition to survivorship care.
✕Less likely to help
Patients who are currently undergoing active treatment for colorectal cancer or those who have not been diagnosed with colorectal cancer may not benefit from this research.
What this research studies
This research focuses on enhancing the understanding and management of colorectal cancer surveillance among survivors. It aims to evaluate an intervention called Current Together After Cancer (CTAC), which is designed to improve knowledge and self-efficacy regarding cancer surveillance. The study will assess how well this intervention helps survivors and their supporters engage in necessary follow-up care, which includes blood tests, imaging, and endoscopy. By leveraging community oncology practices, the research seeks to identify factors that influence the implementation of this intervention.
Why it matters
Potential benefit: If successful, this research could lead to increased rates of cancer surveillance among colorectal cancer survivors, potentially improving early detection of recurrences.
How similar studies have gone: Previous research has shown that interventions aimed at improving patient knowledge and engagement can enhance cancer surveillance outcomes, suggesting a promising approach in this area.
Where this research is happening
-
University of Michigan at Ann Arbor
Ann Arbor, United States Active
Researchers
- Principal investigator: Veenstra, Christine — University of Michigan at Ann Arbor
- Study coordinator: Veenstra, Christine
Related research
Other NIH-funded projects on the same topics.
-
A practical plan to help colorectal cancer survivors keep up with surveillance tests
A practical trial tests a support program called CTAC to help colorectal cancer survivors and their caregivers stay on track with recommended follow-up tests.
-
Improving Follow-Up Care for Colorectal Cancer Survivors
This project offers a new program to help colorectal cancer survivors and their loved ones better understand and follow recommended check-ups after treatment.
-
Improving colorectal cancer screening for Alaska Native people using a new stool DNA test
This study is looking at a new at-home stool DNA test for colorectal cancer to see if it can help more people in Alaska Native communities get screened and reduce cancer deaths, all while working closely with local health organizations to make sure it fits their needs.
-
Improving colorectal cancer screening and follow-up care.
This study is working to help more people get screened for colorectal cancer and receive the follow-up care they need, especially those who haven't been screened much before, so that everyone can have better access to important health checks and improve their overall health.
-
Cognitive behavioral therapy and trazodone for insomnia phenotypes with high blood pressure
A clinical study tests how CBT-I and the sleep drug trazodone work for adults with insomnia and high blood pressure, focusing on a specific sleep duration pattern.
-
Shorter antifungal treatment for kids with candidemia
A multi-center pediatric trial tests whether a shorter, 7 extra days of antifungal therapy after an initial 7 days is just as good as the standard 14-day approach for kids with candidemia who are improving on echinocandin therapy.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.